Proteomic analysis of pleural effusion from lung adenocarcinoma patients by shotgun strategy

被引:15
|
作者
Sheng, Shu-hong [1 ]
Zhu, Hui-li [1 ]
机构
[1] Fudan Univ, Huadong Hosp, Dept Resp Med, Shanghai 200040, Peoples R China
关键词
Biomarker; Malignant pleural effusion; Proteomic; Shotgun; MASS-SPECTROMETRY; 2-DIMENSIONAL ELECTROPHORESIS; CELL-LINES; GENE; PROTEINS; IDENTIFICATION; RECOGNITION; DISCOVERY; DYNAMICS; DOMAINS;
D O I
10.1007/s12094-013-1054-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To construct a protein catalogue of malignant pleural effusion from lung adenocarcinoma patients and to screen the potential candidates of biomarkers for diagnostic value in human lung adenocarcinoma. Five malignant pleural effusion samples of lung adenocarcinoma patients were collected from January 2009 to September. A composite sample was analyzed using shotgun strategy. Pleural effusion samples were separated by means of SDS-PAGE. Proteomic analysis was performed by 1D-LC-MS/MS, and then the proteins were identified using SEQUEST software and protein database search. Among 230 unique proteins, 123 proteins were identified with higher confidence levels (at least two unique peptide sequences matched). Most of these proteins have been reported in plasma. However, there are 7 proteins, including JUP protein, suprabasin, annexin A2, transforming growth factor-beta-induced protein ig-h3 (beta ig-h3), V-set and immunoglobulin domain-containing protein 4 precursor, ifapsoriasin 2 and actin, cytoplasmic 1 have not been reported in serum. Seven proteins may represent potential candidates of biomarkers. Annexin A2 is of special interest since it may play a role in the regulation of intercellular adhesion and cell proliferation.
引用
收藏
页码:153 / 157
页数:5
相关论文
共 50 条
  • [21] Liquid biopsy approaches for pleural effusion in lung cancer patients
    Gayathri Baburaj
    Rama Rao Damerla
    Karthik S Udupa
    Preetiparna Parida
    Murali Munisamy
    Jill Kolesar
    Mahadev Rao
    Molecular Biology Reports, 2020, 47 : 8179 - 8187
  • [22] Outcomes of bevacizumab combined with chemotherapy in lung adenocarcinoma-induced malignant pleural effusion
    Tao, Hong
    Meng, Qiyi
    Li, Mingzhi
    Shi, Liang
    Tang, Junfang
    Liu, Zhe
    THORACIC CANCER, 2018, 9 (02) : 298 - 304
  • [23] Structural Basis for Hyperpermeability of Tumor Vessels in Advanced Lung Adenocarcinoma Complicated by Pleural Effusion
    Damianovich, Maya
    Siloni, Goni Hout
    Barshack, Iris
    Simansky, David A.
    Kidron, Debora
    Dar, Erel
    Avivi, Camila
    Onn, Amir
    CLINICAL LUNG CANCER, 2013, 14 (06) : 688 - 698
  • [24] Liquid biopsy approaches for pleural effusion in lung cancer patients
    Baburaj, Gayathri
    Damerla, Rama Rao
    Udupa, Karthik S.
    Parida, Preetiparna
    Munisamy, Murali
    Kolesar, Jill
    Rao, Mahadev
    MOLECULAR BIOLOGY REPORTS, 2020, 47 (10) : 8179 - 8187
  • [25] Diagnostic value of immune-related biomarker FAM83A in differentiating malignant from benign pleural effusion in lung adenocarcinoma
    Liu, Hangfeng
    Yao, Jia
    Liu, Yulan
    Wu, Liping
    Tan, Zhiwei
    Hu, Jie
    Chen, Shigao
    Zhang, Xiaolin
    Cheng, Shuanghua
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [26] Use of an implantable pleural catheter for trapped lung syndrome in patients with malignant pleural effusion
    Pien, GW
    Gant, MJ
    Washam, CL
    Sterman, DH
    CHEST, 2001, 119 (06) : 1641 - 1646
  • [27] Small Cell Lung Cancer and Pleural Effusion: An Analysis from a District General Hospital
    Nathaniel Keidan
    Avinash Aujayeb
    Pulmonary Therapy, 2023, 9 : 359 - 365
  • [28] Small Cell Lung Cancer and Pleural Effusion: An Analysis from a District General Hospital
    Keidan, Nathaniel
    Aujayeb, Avinash
    PULMONARY THERAPY, 2023, 9 (03) : 359 - 365
  • [29] Proteomic Analysis of Lung Tissues From Patients With Pulmonary Arterial Hypertension
    Abdul-Salam, Vahitha B.
    Wharton, John
    Cupitt, John
    Berryman, Mark
    Edwards, Robert J.
    Wilkins, Martin R.
    CIRCULATION, 2010, 122 (20) : 2058 - U282
  • [30] Levels of PEDF in pleural effusions from lung adenocarcinoma and benign disease patients
    Sanchez-Otero, Nuria
    Blanco-Prieto, Sonia
    Vazquez-Iglesias, Lorena
    Paez de la Cadena, Maria
    Fernandez-Villar, Alberto
    Isabel Botana-Rial, Maria
    Javier Rodriguez-Berrocal, Francisco
    DISEASE MARKERS, 2013, 34 (06) : 425 - 430